Molecular Determinants of Ethionamide Resistance in Clinical Isolates of <i>Mycobacterium tuberculosis</i>
Background: Ethionamide and prothionamide are now included in group C of the WHO recommended drugs for the treatment of tuberculosis resistant to rifampicin and multidrug-resistant tuberculosis. The clinical relevance of ethionamide and prothionamide has increased with the wide spread of resistant t...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2022-01-01
|
| Serija: | Antibiotics |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2079-6382/11/2/133 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|